281 related articles for article (PubMed ID: 9042043)
1. Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler.
Toogood JH; White FA; Baskerville JC; Fraher LJ; Jennings B
J Allergy Clin Immunol; 1997 Feb; 99(2):186-93. PubMed ID: 9042043
[TBL] [Abstract][Full Text] [Related]
2. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.
Piquet J; Zuck P; Dennewald G; Dugue P; Grivaux M; Brun P; Severac JC; Ostinelli J; Cheeseman KH
Adv Ther; 1996; 13(1):38-50. PubMed ID: 10172710
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.
Agertoft L; Pedersen S
J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma.
Agertoft L; Pedersen S; Nikander K
J Aerosol Med; 1999; 12(3):161-9. PubMed ID: 10623332
[TBL] [Abstract][Full Text] [Related]
5. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.
Selroos O; Halme M
Thorax; 1991 Dec; 46(12):891-4. PubMed ID: 1792636
[TBL] [Abstract][Full Text] [Related]
6. A 1-year comparison of turbuhaler vs pressurized metered-dose inhaler in asthmatic patients.
Pauwels RA; Hargreave FE; Camus P; Bukoski M; Ståhl E
Chest; 1996 Jul; 110(1):53-7. PubMed ID: 8681664
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and tolerance of terbutaline and budesonide administered via a pressurized aerosol inhaler or a Turbohaler in asthmatic patients].
Zellweger JP; Anderhub HP; Langloh P
Schweiz Rundsch Med Prax; 1993 May; 82(19):561-4. PubMed ID: 8506434
[TBL] [Abstract][Full Text] [Related]
8. Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer.
Goldberg S; Einot T; Algur N; Schwartz S; Greenberg AC; Picard E; Virgilis D; Kerem E
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):566-71. PubMed ID: 12487221
[TBL] [Abstract][Full Text] [Related]
9. Beta 2-agonists administered by a dry powder inhaler can be used in acute asthma.
Nana A; Youngchaiyud P; Maranetra N; Boe J; Löfdahl CG; Selroos O; Ståhl E
Respir Med; 1998 Feb; 92(2):167-72. PubMed ID: 9616507
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler.
Thorsson L; Edsbäcker S; Källén A; Löfdahl CG
Br J Clin Pharmacol; 2001 Nov; 52(5):529-38. PubMed ID: 11736861
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the lung deposition of budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in asthmatic patients.
Hirst PH; Bacon RE; Pitcairn GR; Silvasti M; Newman SP
Respir Med; 2001 Sep; 95(9):720-7. PubMed ID: 11575892
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics.
Bisgaard H; Nikander K; Munch E
Respir Med; 1998 Jan; 92(1):44-9. PubMed ID: 9519224
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
[TBL] [Abstract][Full Text] [Related]
14. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group.
Nelson HS; Bernstein IL; Fink J; Edwards TB; Spector SL; Storms WW; Tashkin DP
Chest; 1998 May; 113(5):1264-71. PubMed ID: 9596304
[TBL] [Abstract][Full Text] [Related]
15. Importance of the inhalation device on the effect of budesonide.
Agertoft L; Pedersen S
Arch Dis Child; 1993 Jul; 69(1):130-3. PubMed ID: 8024295
[TBL] [Abstract][Full Text] [Related]
16. Budesonide aqueous nasal spray and pressurized metered dose inhaler in the treatment of adult patients with seasonal allergic rhinitis.
Day J; Alexander M; Drouin M; Frankish C; Mazza J; Moote W; Patel P; Ramsdale H; Yang W
Am J Rhinol; 1997; 11(1):77-83. PubMed ID: 9065352
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and safety of budesonide Turbuhaler in adults.
Hultquist C
J Aerosol Med; 1994; 7(Suppl 1):S63-6. PubMed ID: 10147082
[TBL] [Abstract][Full Text] [Related]
18. Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler.
Pitcairn G; Reader S; Pavia D; Newman S
J Aerosol Med; 2005; 18(3):264-72. PubMed ID: 16181001
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of budesonide Turbuhaler as compared to MDIs in children.
Pedersen S
J Aerosol Med; 1994; 7(Suppl 1):S67-71. PubMed ID: 10147083
[TBL] [Abstract][Full Text] [Related]
20. Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler.
Engel T; Heinig JH; Malling HJ; Scharling B; Nikander K; Madsen F
Allergy; 1989 Apr; 44(3):220-5. PubMed ID: 2653086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
